A clinical laboratory automation system using a single calibrator.

JP2024501976A5Active Publication Date: 2024-12-03BECKMAN COULTER INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023539271
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-12-30
Filing Date
2021-11-23
Publication Date
2024-12-03
Estimated Expiration
2041-11-23

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

External calibration curves rely on external calibrators containing known concentrations of target analytes that may degrade over time, leading to inaccurate results. Generating a new calibration curve often requires preparing several calibrators to obtain the calibration points required to generate the calibration curve. Preparing the calibrators required for a multi-point calibration curve requires operator preparation time and may result in handling errors. The claimed and described technology provides a clinical laboratory automation system that includes a fluid handling system, an analyzer component, and a mass spectrometer. The clinical laboratory automation system can provide automated calibration using one calibrator to prepare one or more calibrator dilutions used to generate a calibration curve for the quantitative measurement of a target analyte in a sample.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] (Related Applications) This patent application claims priority benefit of U.S. Provisional Patent Application No. 63 / 131,927, filed December 30, 2020, the contents of which are incorporated herein by reference in their entirety.

[0002] (Field) Various aspects of the present disclosure relate to automated calibration using a calibrator to prepare one or more calibrator dilutions used to generate a calibration curve for the quantitative measurement of a target analyte in a sample. Another aspect of the invention provides automated assessment of pipettor dispense volume and adjustment of the pipettor actuator to deliver a precise dispense volume. [Background technology]

[0003] Mass spectrometry (MS) is an analytical technique used to determine the elemental composition of samples, quantify the mass of particles and molecules, and elucidate the chemical structure of molecules. Various types of MS with high specificity, such as liquid chromatography (LC-MS), gas chromatography (GC-MS), and matrix-assisted laser desorption / ionization / time of flight (MALDI-TOF MS), are increasingly being used in clinical diagnostics. These MS techniques overcome many of the limitations of immunological assays (e.g., nonspecific binding and cross-reaction of analytes) and offer many advantages.

[0004] Quantification by MS can be performed using external calibration curves. External calibration curves rely on external calibrators that contain known concentrations of the target analyte. These calibrators can degrade over time, leading to inaccurate results. Generating a new calibration curve often requires preparing several calibrators and obtaining the calibration points required to generate the calibration curve. Preparing the calibrators required for a multi-point calibration curve requires operator preparation time and can lead to handling errors. For example, some assays require at least a five-point external calibration curve.

[0005] Embodiments of the present invention address these calibration challenges and other challenges individually and collectively.

[0006] Further limitations and drawbacks of conventional and conventional approaches will become apparent to those skilled in the art through comparison of such systems with certain aspects of the present disclosure as described in the remainder of this application with reference to the drawings. Summary of the Invention [Means for solving the problem]

[0007] One aspect provides automated calibration using a calibrator to prepare one or more calibrator dilutions that are used to generate a calibration curve for the quantitative measurement of a target analyte in a sample. Aspects of the invention provide automated assessment of pipettor dispense volume and adjustment of the pipettor actuator to deliver a precise dispense volume.

[0008] Another aspect is directed to a clinical laboratory automation system comprising: (i) a fluid handling system comprising a container handler, at least one fluid container, and a pipettor arrangement; (ii) an analytical component; and (iii) a mass spectrometer. The fluid handling system is configured to dispense at least one fluid from the pipettor arrangement into the at least one fluid container. The mass spectrometer is configured to at least evaluate a property of the at least one fluid, thereby producing a corresponding set of values. The corresponding set of values ​​can be used to calibrate the analytical component. The clinical laboratory automation system can include a control system configured to control the fluid handling system, the analyzer component, and the mass spectrometer.

[0009] Some aspects may include an integrated clinical laboratory automation system including an analytical component integrated with a mass spectrometer and a fluid handling system integrated with the analytical component and / or the mass spectrometer. In some embodiments, the analytical component includes an immunoassay analyzer, a clinical chemistry analyzer, a protein chemistry analyzer, a hematology analyzer, or a urinalysis analyzer.

[0010] Another aspect is directed to a method of calibrating an immunoassay analyzer or a clinical chemistry analyzer, the method being performed by a clinical laboratory automation system comprising: (i) a fluid handling system comprising a container handler, at least one fluid container, and a pipettor arrangement; (ii) an analyzer component; and (iii) a mass spectrometer. In one embodiment, the method includes dispensing a first required volume of a diluent fluid into the fluid container from a first pipettor in the pipettor arrangement of the fluid handling system, dispensing a second required volume of a calibrator into the same fluid container from a second pipettor in the pipettor arrangement of the fluid handling system to produce a dilution series including at least one dilution of the calibrator, performing an evaluation of concentrations of the at least one dilution of the calibrator from the dilution series by the mass spectrometer, generating a corresponding set of values, thereby generating an RLU-dose calibration curve, and calibrating the immunoassay analyzer or clinical chemistry analyzer at least in part using the RLU-dose calibration curve. In an alternative method, the immunoassay analyzer or clinical chemistry analyzer includes an RLU-dose master calibration curve and the corresponding values ​​are used to adjust the RLU-dose master calibration curve, thereby calibrating the immunoassay analyzer or clinical chemistry analyzer.

[0011] A further aspect is directed to a method of calibrating an immunoassay analyzer or a clinical chemistry analyzer, the method being performed by a clinical laboratory automation system comprising: (i) a fluid handling system comprising a container handler, at least one fluid container, and a pipettor arrangement; (ii) a sample pipettor station; (iii) an analyzer component; and (iv) a mass spectrometer. The method includes dispensing a first required volume of a diluent fluid into the fluid container from a first pipettor in the pipettor arrangement of the fluid handling system, dispensing a required volume of a calibrator from the sample pipettor station into the same fluid container to produce a dilution series including at least one dilution of the calibrator, performing an evaluation of concentrations of the at least one dilution of the calibrator from the dilution series by the mass spectrometer, generating a corresponding set of values, thereby generating an RLU-dose calibration curve, and calibrating the immunoassay analyzer or clinical chemistry analyzer at least in part using the RLU-dose calibration curve.

[0012] Another aspect is directed to a method of adjusting a pipettor dispense volume, the method being implemented by a clinical laboratory automation system comprising: (i) a fluid handling system comprising a container handler, at least one fluid container, at least a first pipettor, and a second pipettor, at least one pump driven by an actuator and associated with the first and / or second pipettors, (ii) an analyzer component, and (iii) a mass spectrometer. The method includes dispensing a first requested volume of a first diagnostic reagent including an analyte from the first pipettor into the fluid container, dispensing a second requested volume of a second diagnostic reagent including an antibody from the second pipettor into the same fluid container, quantifying the mixture of diagnostic reagents by the mass spectrometer, generating a corresponding set of values, evaluating for a pipettor dispense inaccuracy using at least the corresponding set of values, and adjusting the actuator as necessary to dispense a correct pipettor dispense volume if a dispense inaccuracy is determined.

[0013] Another aspect is directed to a method of providing variable dilution of a fluid, the method being performed by a clinical laboratory automation system including a fluid handling system including a container handler and a pipettor arrangement including at least a first fluid container and at least a first pipettor and a second pipettor, the fluid handling system configured to produce a set of serial dilutions of a calibrator, the method including providing a calibrator, providing a diluent, dispensing a first desired volume of the diluent from the first pipettor into the first fluid container, and dispensing a first desired volume of the calibrator from the second pipettor into the same fluid container.

[0014] A further aspect is directed to a method of providing variable dilution of a fluid, the method being performed by a clinical laboratory automation system including a fluid handling system including a sample pipetter station, a container handler, at least a first fluid container, and a pipetter arrangement including at least a first pipetter, the fluid handling system being configured to produce a set of serial dilutions of a calibrator, the method including providing the calibrator, providing a diluent, dispensing a first required volume of the diluent from the first pipetter into the first fluid container, and dispensing a required volume of the calibrator from the sample pipetter station into the same fluid container.

[0015] These and other embodiments of the invention are described in further detail below with reference to the drawings. [Brief description of the drawings]

[0016] Embodiments of the present disclosure will now be described, by way of example only, with reference to the accompanying figures.

[0017] [Figure 1] FIG. 1 shows a block diagram of a clinical laboratory automation system in accordance with one embodiment of the present invention.

[0018] [Figure 2A]FIG. 2A shows a schematic diagram of analyzer components in a clinical laboratory automation system according to one embodiment of the present invention.

[0019] [Figure 2B] FIG. 2B shows a schematic diagram of an alternative embodiment of an analyzer component in a clinical laboratory automation system according to another embodiment of the present invention.

[0020] [Diagram 3] FIG. 3 shows an illustrative flow chart diagram illustrating the operational steps for operating the fluid handling system to prepare a calibration dilution series.

[0021] [Figure 4] FIG. 4 shows an illustrative flow chart diagram showing an operational procedure for operating a fluid handling system to prepare a reagent mixture for evaluating pipettor dispense volumes.

[0022] [Diagram 5] FIG. 5 shows a block diagram of a mass spectrometer.

[0023] [Figure 6] FIG. 6 shows a portion of a mass spectrometer that uses the electrospray method.

[0024] [Figure 7] FIG. 7 shows the structure of an ion detector used in a mass spectrometer.

[0025] [Figure 8] FIG. 8 shows a flow chart illustrating a calibration curve generation process according to an embodiment of the present invention.

[0026] [Figure 9] FIG. 9 shows a flow chart illustrating a process for evaluating and adjusting pipettor dispense volume according to one embodiment of the present invention.

[0027] [Figure 10A] FIG. 10A illustrates the extent to which the calibration signal of a single thyroid stimulating hormone calibrator dilution curve can degrade over time.

[0028] [Figure 10B] FIG. 10B shows a single thyroid stimulating hormone calibration dilution curve prepared according to an embodiment of the present invention.

[0029] [Figure 10C] FIG. 10C illustrates the adjustment of a master calibration curve according to an alternative embodiment of the present invention.

[0030] [Figure 11] FIG. 11 shows the analysis of diagnostic reagents on a mass spectrometer. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0031] Various embodiments will now be described in detail with reference to the drawings, in which like reference numbers represent like parts and assemblies throughout the several views. It is to be understood that the present disclosure is not limited to the specific methodology, protocols, and reagents described herein, and as such may vary. It is also to be understood that the terminology used herein is for the purpose of describing specific embodiments only, and is not intended to limit the scope of the present disclosure or the appended claims.

[0032] As used in this specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise.

[0033] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs.

[0034] Some embodiments may be used to calibrate analyzers used to detect the presence, absence, or concentration of analytes in biological or chemical samples. Biological samples, such as biofluids, may include, but are not limited to, blood, plasma, serous fluid, or other bodily fluids or excretions (including, but not limited to, saliva, urine, cerebrospinal fluid, tears, sweat, gastrointestinal fluid, amniotic fluid, mucosal fluid, pleural fluid, sebum oil, exhaled breath, etc.). Chemical samples may include any suitable type of sample that contains chemicals (including water samples).

[0035] Prior to discussing certain embodiments, certain terms may be explained in further detail.

[0036] The term "analyzer" or "analytical component" may include any suitable instrument capable of analyzing a sample, such as a component, fluid, or biological sample. Examples of analyzers or analytical components include mass spectrometers, immunoassay analyzers, hematology analyzers, microbiology analyzers, and / or molecular biology analyzers.

[0037] In some embodiments, the analyzer can be an immunoassay analyzer (typically detecting a label (chemiluminescence, electrochemiluminescence fluorescence, radioactivity, isotopes, DNA, etc.)) or a label-free system. Other types of analyzers can include hematology analyzers, microbiology analyzers, chemistry analyzers, urine analyzers, biochemistry analyzers, and / or molecular biology analyzers. When analyzing biological samples, one or more of these types of analyzers in any suitable combination can be used to analyze the biological sample.

[0038] Hematology analyzers can be used to perform complete blood counts, erythrocyte sedimentation rates (ESR), and / or coagulation tests. Automated cell counters sample blood and use both electrical and optical techniques to quantify, classify, and describe cell populations.

[0039] Microbiology analyzers can function as diagnostic tools to determine the identity of biological organisms. In some embodiments, microbiology analyzers can identify infectious microorganisms. Such analyzers can use biochemicals in multiple small sample test microwells or multi-well panels in a centrifuge rotor that contain different substrates depending on the type of test being performed.

[0040] A molecular biology analyzer can be a device that can analyze a biological sample at its molecular level. Examples of molecular biology analyzers can include nucleic acid analyzers, such as DNA analyzers.

[0041] Chemical analyzers can perform assays on clinical samples such as serum, plasma, urine, and cerebrospinal fluid to detect the presence of analytes related to disease or drugs. Chemical analyzers may use photometry, in which the sample is mixed with an appropriate reagent to produce a reaction that results in a color. The concentration of the analyte determines the intensity of the color produced. A photometer emits light of an appropriate wavelength at the sample and measures the amount of light absorbed, which is directly correlated to the concentration of the analyte in the sample. Another analytical method used within chemical analyzers is Na+. + , K + , Ca + , F - , Cl - , and Li + and the use of ion selective electrodes (ISEs) to measure ions such as ions in water. An ISE is a sensor that determines the concentration of an ion in a solution by measuring current flow through an ion selective membrane.

[0042] The term "analyte" may include a substance whose presence, absence, or concentration is to be determined according to embodiments of the present invention. Exemplary analytes may include, but are not limited to, organic molecules, hormones (such as thyroid hormones, estradiol, testosterone, progesterone, estrogen, etc.), metabolites (such as glucose or ethanol), proteins, lipids, carbohydrates, and sugars, steroids (such as vitamin D), peptides (such as procalcitonin), nucleic acid segments, biomarkers (pharmaceuticals such as antibiotics, benzodiazepines, etc.), drugs (immunosuppressants, narcotics, opioids, etc.), molecules with a regulatory effect on enzymatic processes such as promoters, activators, inhibitors, or cofactors, microorganisms (such as viruses (including EBV, HPV, HIV, HCV, HBV, influenza, norovirus, rotavirus, adenovirus, etc.)), bacteria (such as Helicobacter pylori, Streptococcus, MRSA, Clostridium difficile, Legionella, etc.), fungi, parasites (such as Plasmodium), cells, cell components (such as cell membranes), spores, nucleic acids (such as DNA and RNA), and the like. Embodiments of the invention may also allow for the simultaneous analysis of multiple analytes, either in the same or different classes (e.g., simultaneous analysis of metabolites and proteins), in which analysis of a particular analyte, such as a biomarker, may indicate that a particular medical condition (e.g., disease) is associated with a sample containing the analyte.

[0043] The term "immunoassay" refers to a laboratory method used to determine the amount of an analyte in a sample. It can be based on the interaction of an antibody and an antigen, and due to the degree of selectivity for the analyte (either the antigen or the antibody), an immunoassay can be used to quantitatively determine very low concentrations of an analyte in a test sample. "Immunoanalyzer" or "immunoassay analyzer" can include instruments on which immunoassays based are automated. Dxl TM Systems (Beckman Coulter, CA), AD VIA TM and CENTAUR TM Systems (Siemens Healthcare, Germany), COB AS TMSystem (Roche Diagnostic, Germany), ARCHITECT TM Systems (Abbott, IL), VITROS TM System (Ortho-clinical Diagnostic, NJ), and VIDAS TM A variety of immunoassay analyzers are commercially available, including the ELISA System (Biomerieux, France).

[0044] A "mass spectrometer" is an instrument that can measure the mass and relative concentration of atoms and molecules. One example of a mass spectrometer utilizes elementary magnetic forces on moving charged particles. Essentially, the instrument ionizes a sample and then deflects the ions through a magnetic field based on the mass-to-charge ratio of the ions. Mass spectra can then be used to determine the elemental or isotopic signature of the sample, the masses of the particles and molecules, and to elucidate the chemical structure of molecules, such as peptides and other chemical compounds. Commercially available mass spectrometers can be categorized based on how they sector the mass selection, including time of flight, quadrupole MS, ion traps (including 3D quadrupoles, cylindrical ion traps, linear quadrupole ion traps, orbitraps), Fourier transform ion cyclotron resonance (FTMS), and the like. Alternatively, they can also be sectored based on the ion source (laser desorption, matrix-assisted laser desorption, thermal ionization, plasma, spark source, and the like) or detector (electron multipliers (such as Faraday cups and ion / photon detectors), inductive detectors, and the like). In a preferred embodiment, the mass spectrometer can be a triple quadrupole mass spectrometer.

[0045] The term "calibration" refers to the process of determining the relationship between instrument response (measured response) and known analyte concentration to ensure valid quantification of a sample.

[0046] The term "calibration curve" refers to the mathematical relationship between a measured response and a known analyte concentration. A calibration curve is used to convert relative light unit (RLU) measurements of a sample to a specific quantitative analyte concentration.

[0047] In the specific example provided below, a clinical laboratory automation system including a fluid handling system, an immunological assay analyzer, and a mass spectrometer is described in detail. However, embodiments of the present invention are not so limited. Instead of the immunological assay analyzer, another type of analyzer, such as a chemical analyzer, can be used in place of the immunological assay analyzer. Many of the functions and features in the immunological assay analyzer can also be present in the chemical analyzer (e.g., reagent storage, fraction collection station, sample preparation station, etc.). Furthermore, additional components, such as a sample introduction device, can also be used with the chemical analyzer and mass spectrometer in the clinical laboratory automation system.

[0048] Specific embodiments may include a fluid handling system, which may be separate from or integrated with the analytical component. The fluid handling system may be separate from or at least partially integrated with the mass spectrometer. In some embodiments, the fluid handling system, analytical component, and mass spectrometer are individual components in a modular laboratory automation system. The modular laboratory automation system may have a workflow that includes a pre-analytical portion, a post-analytical portion, and at least one connection to the analytical component. The pre-analytical portion may include a batch loading component, at least one centrifuge, and / or a sample quality detection component. The pre-analytical portion may also include a fluid handling system. The post-analytical portion may include a volume detection component and / or a storage and retrieval component. The retrieval may be automated or manual. Direct tracking sampling may be used to connect, for example, to an immunoassay analyzer or a coagulation instrument. A rack builder unit may be used to connect, for example, to a clinical chemistry analyzer or a hematology analyzer. The mass spectrometer may be offline from the workflow or connected through other analytical connectors known in the art.

[0049] In some embodiments, the fluid handling system, analytical components, and mass spectrometer can be a fully integrated platform. In some embodiments, the fluid handling system is part of a sample preparation station. In some embodiments, the automation system includes a sample introduction station that can transfer samples to the mass spectrometer for analysis. The clinical laboratory automation system also includes a control system that can control the fluid handling system, the analyzer components, and the mass spectrometer.

[0050] FIG. 1 shows a high-level block diagram of a clinical laboratory automation system according to an embodiment of the present invention. The clinical laboratory automation system 100 includes an analyzer component (e.g., an immunoassay analyzer) 102, a mass spectrometer 106, and a fluid handling system 104. The fluid handling system 104 may be integrated with a sample processing system in some embodiments. The automated sample processing system is described in detail in published PCT application WO2018 / 217778, published November 29, 2018, which is incorporated herein by reference in its entirety. The fluid handling system 104 may be physically and / or operatively coupled to the analyzer 102 and the mass spectrometer 106, and in some embodiments, the fluid handling system 104, the analyzer component 102, and the mass spectrometer 106 may form a single instrument. The fluid handling system 104 may be responsible for preparing calibrator dilutions for quantitative calibration of the analyzer components and / or for preparing reagent mixtures for evaluating pipettor dispense volumes. The calibrant dilutions and reagent mixtures can be transferred to the mass spectrometer 106 for analysis.

[0051] The analyzer component 102 may include an immunological assay analyzer, a clinical chemistry analyzer, a protein chemistry analyzer, a hematology analyzer, or a urinalysis analyzer. The analyzer component 102 may include several sample aliquot processing devices to form processed sample aliquots for analysis. Such processing devices may process samples or sample aliquots in any suitable manner. Examples of sample aliquot processing devices include reagent addition stations (e.g., reagent pipetting stations), sample pipetting stations, incubators, washing stations (e.g., magnetic washing stations), sample storage units, etc. The analyzer component 102 may be an automated analyzer component 400.

[0052] A control system 108 may also be present in the clinical laboratory automation system 100. The control system 108 may control the analyzer component 102, the fluid handling system 104, and / or the mass spectrometer 106. The control system 108 may comprise a data processor 108A, a non-transitory computer readable medium 108B, and a data storage device 108C coupled to the data processor 108A. The non-transitory computer readable medium 108B may comprise code executable by the data processor 108A to perform functions described herein. The data processor 108C may store data for processing samples, sample data, or data for analyzing sample data.

[0053] The data processor 108A may include any suitable data computing device or combination of such devices. An exemplary data processor may include one or more microprocessors that cooperate to perform desired functions. The data processor 108A may include a CPU that includes at least one high-speed data processor suitable for executing program components to perform user and / or system generated requests. The CPU may be a microprocessor such as an AMD Athlon, Duron, and / or Opteron, IBM and / or Motorola PowerPC, IBM and Sony Cell processors, Apple M1, Intel Celeron, Itanium, Pentium, Xeon, and / or XScale, etc. processors.

[0054] The computer readable medium 108B and the data storage device 108C may be any suitable device or devices capable of storing electronic data. Examples of memory may include one or more memory chips, disk drives, etc. Such memory may operate using any suitable electrical, optical, and / or magnetic modes of operation.

[0055] The computer readable medium 108B may comprise code executable by the data processor 108A to perform any suitable method. For example, the computer readable medium 108B may comprise code executable by the processor 108A to cause the laboratory automation system to automatically generate a calibration curve using measurements of calibration dilutions from the mass spectrometer 106. In other embodiments, the computer readable medium 108B may comprise code executable by the data processor 108A to cause the laboratory automation system to perform a method that includes having the fluid handling system prepare a reagent mixture, such as a mixture of analyte and antibody or antigen, that is used to evaluate whether there is an inaccuracy in the pipettor dispense volume based on the molecular weight shift. If an inaccuracy is detected, the data processor 108A may cause the fluid handling system 104 to adjust the pipettor dispense volume.

[0056] The fluid handling system 104 comprises a container handler 101, at least one fluid container 103, and a pipettor arrangement 421. The container handler 101 can be any device used to handle or transport a container. Examples of suitable container handlers include, but are not limited to, a pick-and-place device, such as a pick-and-place transport gantry, a transport shuttle, such as an extended linear reaction shuttle, or a combination of a pick-and-place transport gantry and an extended linear reaction shuttle. The fluid container 103 can be a cuvette, a tube, a vial, a well in a puck, etc. In some embodiments, the fluid handling system 104 comprises multiple fluid containers 103, 103a, 103b, 103c, such as two containers, three containers, or four or more containers. The pipettor arrangement 421 comprises at least one pipettor 404 (see FIGS. 2A and B) that dispenses a measured volume of at least one fluid into the fluid container 103. In some embodiments, the pipettor arrangement 421 may include a second pipettor 405 or may have three or more pipettors. Each pipettor may include an ultrasonic transducer and a probe. The ultrasonic transducer applies ultrasonic vibrations to the tip of the probe to mix reagents in a reagent pack, mix contents in a fluid container, clean the probe after each use, and sense the level of fluid in the fluid container. Each pipettor may also include a fluid pump 414 and associated valves for aspirating diluents, calibrants, and reagents into the probe. The fluid pump 414 may be driven by an actuator 415, such as a motor. In some embodiments, the motor is a stepper motor that allows for precise adjustment of the volume of fluid dispensed by the pipettor.

[0057] The fluids dispensed by the pipettor arrangement 421 can be calibrators, diagnostic reagents, diluents, or mixtures thereof, and patient samples. In some embodiments, a separate sample pipettor station may be used to dispense patient samples. A separate sample pipettor may also be used to dispense calibrators in some embodiments. In some embodiments, the calibrators and / or diagnostic reagents comprise analytes. Examples of analytes that may be analyzed in a clinical laboratory automation system include thyroid stimulating hormone (TSH), prostate specific antigen (PSA), troponin, vitamin D, and free thyroxine (T4). Diagnostic reagents may also comprise antibodies or antigens. Diluents that may be used to prepare calibrator dilutions or patient samples include TRIS buffer and bovine serum albumin (BSA) buffer.

[0058] 2A shows a block diagram of an automated analyzer component 400 that may be used in a clinical laboratory automation system according to an embodiment. The basic structural and functional modules of the automated analyzer component 400 may include a sample providing unit 401; a fraction collection station with a main sample pipetting station 402; a bulk container feeder 403; a fluid handling system including a pipettor arrangement 421 that may include a first pair of dual reagent pipettors 404 and 405 and a second pair of dual reagent pipettors 406 and 407; a container handler that may include a first pick-and-place gripper 408, a second pick-and-place gripper 409, and a third pick-and-place gripper 410; an incubator / wash / read station 412; a sample storage 411; and a reagent storage 413. Optionally, the sample and / or reagent storage may be refrigerated. The sample presentation unit 401 can be used to load calibrators and matrices and reagent packs and transport them to the pipettor position.

[0059] One or more of the pipettors 404, 405, 406, 407 of the pipettor arrangement 421 may be used to prepare calibrator dilutions for use in calibrating analyzer components. The pipettors 404, 405, 406, 407 may also be used to prepare diagnostic reagent mixtures that may be used to evaluate pipettor dispense volumes. The four pipettors 404, 405, 406, 407 may be arranged as two dual pipettors and may be independent of each other. Each of the four pipettors 404, 405, 406, 407 may have its own fluid pump and valve, watchtower, reaction vessel carrier, and probe. Each of the fluid pumps may be driven by an actuator, such as a motor, preferably a stepper motor. Although four pipettors 404, 405, 406, 407 are shown, it should be understood that embodiments of the invention may include more or fewer pipettors.

[0060] Three pick-and-place grippers 408, 409, 410 may be used to transport sample and reaction vessels (fluid containers) between various modules of the analyzer component. The first pick-and-place gripper 408 may be used to transport fluid containers between the bulk vessel feeder 403 or sample storage 411 and the pipettor arrangement 421. The second pick-and-place gripper 409 may be used to transport fluid containers between the pipettor arrangement 421 and the incubator / wash / read station 412. The third pick-and-place gripper 410 may be used to transport fluid containers between the incubator of the incubator / wash / read station 412 and a wash wheel (an example of a wash station). A detailed description of the configuration and function of the pick-and-place grippers 408, 409, 410 is provided in U.S. Pat. No. 7,128,874, which is incorporated herein by reference in its entirety. It should be understood that embodiments of the present invention may have more or less pick-and-place grippers. A more detailed description of the automated analyzer components is provided in PCT Published Application No. WO2018 / 217778, which is incorporated herein by reference in its entirety.

[0061] FIG. 2B shows a block diagram of an alternative embodiment of an automated analyzer component 400a, where like numbers represent similar structures as shown in FIG. 2A. In this embodiment, a main sample pipetter station 402a may be used to dispense patient samples for processing, as well as dispense calibrators used to prepare calibrator dilutions. In this embodiment, one or more of pipetters 404, 405, 406, or 407 dispense reagents used to prepare calibrator dilutions, and the sample pipetter station 402a dispenses calibrators. As in the embodiment of FIG. 2A, pick-and-place grippers 408, 409, and 410 may be used to transport samples and fluid containers between various modules of the analyzer component. Assay incubation, washing, and reading steps may be performed in the incubation station 412a, washing station 412b, and reading station 412c.

[0062] FIG. 3 shows an illustrative flow chart diagram showing the basic operational steps for operating the fluid handling system to prepare a calibrator dilution series. In the process, referring to FIGS. 1, 2A, and 2B, an operator loads a matrix pack containing the appropriate diluent for the assay requiring calibration in the clinical laboratory automation system. The operator also loads calibrator vials, or other fluid containers, containing high concentrations of the appropriate calibrator onto the rack. The calibrator may contain a single analyte or may contain multiple analytes. If multiple analytes are present in the calibrator requiring different diluents or reagents, the different diluents or reagents may be provided through different wells in the matrix pack. A calibrator card associated with the calibrator provides an identifier, such as a barcode, for each calibrator dilution. In some embodiments, the operator manually scans the barcode information and communicates the information to the control system. In a preferred embodiment, the calibration card may be attached directly to the rack so that the analyzer components may directly read the calibrator information and communicate it to the control system 108. The calibrator rack is advanced to the pipettor location 421 where the identifiers on the calibrator vials are read to identify the assays requiring calibration. At the same time, the fluid containers needed to prepare the calibrator dilutions are delivered to the pipettor location 421 by a container handler such as the pick-and-place gripper 408.

[0063] In the pipettor arrangement 421, the number of dilutions required to generate a calibration curve is prepared by dispensing a required volume of diluent from the matrix pack into the fluid container 103 from one of the pipettors 404, 405, 406, 407. In the embodiment of Figure 2A, a required volume of a high concentration calibrator is then dispensed into the same fluid container from one of the pipettors 404, 405, 406, 407. In the embodiment of Figure 2B, the fluid container 103 is moved from the pipettor arrangement to the main sample pipettor station 402a, which dispenses a required volume of a high concentration calibrator into the same fluid container. If a second dilution (or more) of calibrator is required, it may be prepared in the second fluid container 103a in the same manner as the first dilution prepared by the respective embodiment (except that the second dilution differs from the first dilution in the required volume of diluent dispensed by the pipettor into the second fluid container 103a). Additional calibrator dilutions may be prepared depending on the number of calibration points required for the calibration curve for a particular assay. Each prepared dilution has a different concentration of calibrator, resulting in a set or series of calibrator dilutions. Examples of a dilution series can be 1 / 1, 1 / 2, 1 / 5, 1 / 10, 1 / 15, 1 / 20. In embodiments, each dilution will be in the range of 1 / 1 to 1 / 200. In some embodiments, each dilution volume is sufficient to perform at least three assay replicates. One set of the dilution series may be transferred to the mass spectrometer 106 for calibrator measurements. The measurements from the mass spectrometer 106 may be used to generate an RLU dose calibration curve. The other two dilution series may be transferred to the analyzer component 102 for assay testing.

[0064] 4 shows an illustrative flow chart diagram showing basic operational steps for operating a fluid handling system to prepare a mixture of diagnostic reagents for use in evaluating pipetter dispense volumes. In the process, referring to FIGS. 1 and 2A, an operator loads a reagent pack into the clinical laboratory automation system. The reagent pack comprises at least two diagnostic reagents, one diagnostic reagent comprising a specimen and a second diagnostic reagent comprising an antibody or antigen. The reagent pack is transferred to the pipetter arrangement 421. At the same time, a container handler 101, such as a pick-and-place gripper 408, provides a fluid container to the pipetter arrangement 421 for dispensing the diagnostic reagents into the fluid container 103. With the reagent pack and fluid container 103 in place, a first pipettor, which may be any one of pipettors 404, 405, 406, 407, uses a precision pump to dispense a first required volume of analyte into the fluid container 103, and a second pipettor, which may be another of pipettors 404, 405, 406, 407, uses a precision pump to dispense a second required volume of antibody or antigen into the same fluid container 103. The diagnostic reagents are allowed to immunoreact and form a mixture. The mixture can be transferred to a mass spectrometer for evaluation.

[0065] A wide variety of mass analyzer systems that may form part of a mass spectrometer can be used in the clinical laboratory automation system according to various embodiments. A suitable mass analyzer system includes two mass separators with an ion fragmenter disposed in the ion flight path between the two mass separators. Examples of suitable mass separators include, but are not limited to, quadrupoles, RF multipoles, ion traps, time-of-flight (TOF), and TOF in conjunction with timed ion selectors. Suitable ion fragmenters include, but are not limited to, those that operate on the principles of collision-induced dissociation (CID, also called collision-assisted dissociation (CAD)), photoinduced dissociation (PID), surface-induced dissociation (SID), post-source decay by interaction with an electron beam (e.g., electron-induced dissociation (BID), electron capture dissociation (BCD)), interaction with thermal radiation (e.g., thermal / blackbody infrared radiation dissociation (BIRD)), post-source decay, or a combination thereof.

[0066] Examples of suitable mass spectrometers include, but are not limited to, those equipped with one or more of a triple quadrupole, a quadrupole linear ion trap (e.g., 4000 Q TRAP® EC / MS / MS system, Q TRAP® LC / MS / MS system), a quadrupole TOF (e.g., QSTAR® LC / MS / MS system), and a TOF-TOF.

[0067] The mass spectrometer can include a triple quadrupole mass spectrometer for selecting parent ions and detecting their fragment daughter ions. In this embodiment, the first quadrupole selects the parent ion. The second quadrupole is maintained at a sufficiently high pressure and voltage, which causes multiple low energy collisions to occur and fragment some of the parent ions. The third quadrupole is selected to transmit the selected daughter ions to the detector. In various embodiments, the triple quadrupole mass spectrometer can include an ion trap disposed between the ion source and the triple quadrupole. The ion trap can be set to collect ions (e.g., all ions, ions with a particular m / z range, etc.) and transmit the selected ions to the first quadrupole by pulsing the end electrode after a fill time, allowing the selected ions to exit the ion trap. The desired fill time can be determined based on, for example, the number of ions, the charge density in the ion trap, the time between elution of different feature peptides, the duty cycle, the decay rate of excited state species, multiply charged ions, or a combination thereof.

[0068] One or more of the quadrupoles in a triple quadrupole mass spectrometer can be configured as a linear ion trap (e.g., by the addition of end electrodes to provide a substantially elongated cylindrical trapping volume within the quadrupole). In various embodiments, the first quadrupole selects the parent ion. The second quadrupole is maintained at a sufficiently high collision gas pressure and voltage so that multiple low-energy collisions occur, fragmenting some of the parent ions. The third quadrupole is selected to trap the fragment ions, and after a fill time, transmits the selected daughter ions to the detector by pulsing the end electrodes, allowing the selected daughter ions to exit the ion trap. The desired fill time can be determined based on, for example, the number of fragment ions, the charge density within the ion trap, the time between elution of different signature peptides, the duty cycle, the decay rate of excited state species, or multiply charged ions, or a combination thereof.

[0069] In some embodiments, the mass spectrometer can include a two quadrupole mass separator and a TOF mass spectrometer to select a parent ion and detect its fragment daughter ions. In various embodiments, the first quadrupole selects the parent ion. The second quadrupole is maintained at a sufficiently high pressure and voltage so that multiple low energy collisions occur and fragment some of the ions, and the TOF mass spectrometer selects the daughter ions for detection, for example, by deflecting ions that appear outside the time window of the selected daughter ion away from the detector, by time gating the detector to the arrival time window of the selected daughter ion, or a combination thereof, by monitoring ions over a mass range that encompasses the daughter ion of interest and the extracted ion chromatogram generated.

[0070] In some embodiments, the mass analyzer can include two TOF mass analyzers and an ion fragmentor (e.g., CID or SID, etc.). In various embodiments, the first TOF selects a parent ion for introduction into the ion fragmentor (e.g., by deflecting ions that appear outside the time window of the selected parent ion away from the fragmentor), and the second TOF mass analyzer selects a daughter ion for detection, e.g., by deflecting ions that appear outside the time window of the selected daughter ion away from the detector, by time gating the detector to the arrival time window of the selected daughter ion, or a combination thereof, by monitoring ions over a mass range encompassing the daughter ion of interest and the extracted ion chromatogram generated. The TOF analyzer can be a linear or reflecting analyzer.

[0071] The mass spectrometer can include a tandem MS-MS instrument that includes a first field-free drift region with a timed ion selector for selecting a parent ion of interest, a fragmentation chamber (or ion fragmentor) for producing daughter ions, and a mass separator for transmitting the selected daughter ions for detection. In various embodiments, the timed ion selector includes a pulsed ion deflector. In various embodiments, the ion deflector can be used as a pulsed ion deflector. The mass separator can include an ion reflector. In various embodiments, the fragmentation chamber is a collision cell designed to cause fragmentation of ions and delayed extraction. In various embodiments, the fragmentation chamber can also serve as a delayed extraction ion source for analysis of the fragment ions by time-of-flight mass spectrometry.

[0072] In some embodiments, ionization can be used to produce structurally specific fragment ions and Q3 MRM ions. The labeling reagent can be fully or partially contained within the structurally specific fragment ions. The method can provide both sensitivity and specificity for the Q3 MRM ions. In some embodiments, ionization can be used to produce predominantly neutral loss fragment ions, which can be selected in Q3 and then fragmented to produce structurally specific ions. These fragment ions can then be used for identification and quantification in a procedure called MSS.

[0073] FIG. 5 shows a block diagram of an exemplary mass spectrometer 600 and an introduction device 601 for introducing a calibrant dilution or a diagnostic reagent mixture into the mass spectrometer. The introduction device 601 can be in an analyzer component in some embodiments. The introduction device 601 can be coupled to the mass spectrometer 600 through a connecting tube 602. The introduction device 601 can introduce the calibrant dilution through the connecting tube 602 into an ion source 603. The ion source 603 can be controlled by an ion source power supply 604 through a signal line 605A. Ions related to the calibrant molecules generated by the ion source 603 are introduced into a mass analysis region 606 and mass analyzed. The mass analysis region 606 is evacuated to a vacuum by a vacuum system 607. The ions so mass analyzed are detected by an ion detector 608. A detection signal is fed to a data processing unit 609 through a signal line 605B. The data processing unit 609 may be a separate unit or may be part of the control system described above.

[0074] FIG. 6 shows a schematic diagram of a part of a mass spectrometer using the electrospray method. FIG. 6 is a cross-sectional view showing the structure of an introduction device 619 coupled to an electrospray ion source. Calibrant dilution or reagent mixture provided from the introduction device 619 is introduced into the capillary tube 621 through a connecting tube 622 and a connection 630 for nebulization. By applying a voltage of the order of kV between the nebulization capillary tube 621 and a counter electrode 632, small charged droplets of the calibrant dilution or reagent mixture are sprayed in a cone shape from the end of the nebulization capillary tube, i.e., the so-called electrospray phenomenon occurs. In the electrospray method, an output 623 for nebulization gas is provided, and a gas such as nitrogen gas is poured from the periphery of the nebulization capillary tube 621, thereby accelerating the vaporization of the small charged droplets. Further, a gas such as nitrogen gas is blown toward the generated small charged droplets from an outlet 624 to vaporize the gas provided on the counter electrode 632 side and accelerate the vaporization of the small charged droplets. The generated ions are introduced into a vacuum section 626 through an ion sampling aperture 625 and are mass analyzed by a mass analysis region 626 under high vacuum.

[0075] FIG. 7 shows the structure of an ion detector. The structure shown in FIG. 7 can be used to improve the signal-to-noise ratio (SIN) in a mass spectrometer. An ion deflection electrode 646 can be provided at the rear of the mass analysis region 648 for mass separation under a high-frequency electric field to deflect the mass-separated ions. The deflected ions are accelerated at a voltage of kV and collide with a dynode 657 to produce secondary electrons. The secondary electrons are emitted from the secondary electron producing dynode 657 with which the ions collide. The emitted secondary electrons are detected by an electron detector 658 such as an electron multiplier. The structure shown in FIG. 7 prevents neutral molecules with no charge, charged droplets, or droplets with no charge from being detected as a signal by the ion detector 648 so that an improvement in S / N is achieved.

[0076] FIG. 8 shows a flow chart illustrating process steps for generating a calibration curve according to an exemplary embodiment. It can be referred to with respect to the automated analyzer component of FIGS. 2A and 2B. In step 802, a matrix pack and calibrant are loaded into the presentation unit 401 in the automated analyzer component 400. In step 804, one of the pipettors 404, 405, 406, 407 delivers a required volume of diluent into the fluid container 103 provided by the bulk container feeder 403. In step 806, the same pipettor or another of the pipettors 404, 405, 406, 407 in the embodiment of FIG. 2A of the automated analyzer component delivers a required volume of calibrant into the same fluid container 103. In the embodiment of FIG. 2B, dispensing 806 of calibrant is performed by the sample pipettor station 402a. Steps 804 and 806 are repeated for each calibrant dilution to be prepared. In step 808, a series of calibrator dilutions are transferred to the mass spectrometer 106 for measurement. In step 810, the measurements from the mass spectrometer 106 are used to automatically generate an RLU dose calibration curve. An actual sample can then be analyzed in the analyzer component 102 based on the calibration curve generated in step 810 such that a quantitative value of the analyte in the sample can be obtained.

[0077] It should be understood that depending on the particular assay test to be calibrated, additional process steps may need to be performed. For example, magnetic beads or particles may be added and incubation, separation, and / or washing steps may be performed. Other processing steps may include immunopurification processing steps. In an immunopurification process, after the analyte is captured by the antibody, any unbound molecules are washed away in a washing process. In a subsequent elution step, the analyte is subsequently released from the antibody using a buffer and an eluent. The eluent containing the "purified" target may be characterized as a processed sample aliquot, which is then collected and analyzed by a mass spectrometer. Other processing steps may include protein precipitation processing and SISCAPA type processing steps. Rather than measuring intact proteins directly by mass spectrometry, SISCAPA utilizes proteolysis (e.g., with the enzyme trypsin) to cleave the sample proteins into smaller peptides that are ideally amenable to quantification by mass spectrometry. By selecting a target peptide whose configuration occurs only in the selected target protein (a so-called "proteotypic" peptide), the target peptide can serve as a direct quantitative surrogate for the target protein.

[0078] FIG. 9 shows a flow chart illustrating process steps for preparing a diagnostic reagent mixture that can be used to evaluate the dispense volume of a selected pipettor according to an embodiment of the present invention. Reference can be made to FIG. 1 and FIG. 2A. In step 902, a reagent pack comprising a first diagnostic reagent containing an analyte and a second diagnostic reagent comprising an antibody or antigen is loaded into a presentation unit 401 in an automated analyzer 400. In step 904, one of the pipettors 404, 405, 406, 407 delivers a required volume of the first diagnostic reagent into a fluid container 103 provided by a bulk vessel feeder 403. In step 906, another of the pipettors 404, 405, 406, 407 delivers a required volume of the second diagnostic reagent into the same fluid container 103. The mixture of diagnostic reagents in the fluid container 103 can be mixed using any suitable mixing process. In step 908, the fluid container 103 containing the mixture of reagents is incubated to allow the formation of analyte / antibody or analyte / antigen complexes. In step 910, the analyte / antibody or analyte / antigen complexes are transferred to the mass spectrometer 106 to quantify the number of analyte / antibody or analyte / antigen complexes by molecular weight. In step 912, a bias is calculated based on the ratio of the measured signal from the mass spectrometer to the expected signal. If the measured signal does not meet a certain threshold, such as 90% of the expected signal, a dispense volume inaccuracy is detected in the selected pipettor being evaluated. If an inaccuracy is detected, the dispense volume of the selected pipettor requires adjustment. In step 914, a factor of 1 / bias value is applied to the actuator for the dispense pump associated with the target pipettor, and the actuator is adjusted as necessary to compensate for the detected dispense volume inaccuracy. In some embodiments, the actuator 415 can be a stepper motor.

[0079] The clinical laboratory automation system 100 according to various embodiments may be used to measure or determine the presence of a variety of analytes, such as hormones, drugs of abuse, and tumor markers, in one or more samples. For many of these analytes, the clinical laboratory automation system 100 may provide automated calibration using a single calibrator to prepare one or more calibrator dilutions that are used to generate a calibration curve for the quantitative measurement of the target analyte.

[0080] Further examples are provided below.

[0081] (Example)

[0082] Example 1: Single Thyroid Stimulating Hormone Calibrator Dilutions

[0083] Measuring thyroid stimulating hormone (TSH) is useful in assessing thyroid function and monitoring patients undergoing thyroid replacement therapy. TSH is part of the hypothalamic-pituitary-thyroid axis that regulates the body's metabolism. The hypothalamus secretes thyrotropin releasing hormone (TRH), which stimulates the pituitary gland to secrete TSH. TSH causes the release of thyroid hormones, T3 (triiodothyronine) and T4 (thyroxine), which control metabolic functions within cells. When excessive amounts of T3 or T4 circulate, production of TRH stops, resulting in a process that is controlled by a negative feedback loop.

[0084] Quantitative analysis of TSH in intrapatient samples requires preliminary calibration of the instrument response of the instrumentation and devices used to detect the amount of TSH in the sample being analyzed. Calibration is usually performed with known concentrations of the target analyte present in the sample to be analyzed. The known concentrations can be used to construct a calibration curve that graphically plots the mathematical relationship between the measured response and the known analyte concentrations. One difficulty that can arise is that the calibration signal (i.e., relative light units) can degrade over time while the assigned dose value remains the same. This difficulty is illustrated in FIG. 10A.

[0085] A new calibration curve can be prepared by the following method: A single calibrator TSH is loaded onto a fluid handling system integrated with an immunoassay analyzer. A series of dilutions is generated by first dispensing the diluent and then the calibrator. The diluted TSH calibrator is then sent to a mass spectrometer. The concentration of each calibrator dilution is quantified on the mass spectrometer and the measured concentration assigned to each calibrator dilution is provided on the immunoassay analyzer. A new calibration curve, depicted in FIG. 10B, is then plotted on the immunoassay analyzer.

[0086] Example 2: Master Calibration Curve Adjustment

[0087] For some embodiments, a manufacturer may generate a master calibration curve for a clinical laboratory automation system at a manufacturing facility. The manufacturer provides the customer with specific calibration information, such as a barcode or 2D code attached to the reagent package, and one or two adjustment calibrators. The user can test the calibrators on their analyzer and then adjust the RLU-dose calibration curve on-site based on the values ​​generated for the calibrators. Figure 10C illustrates this adjustment.

[0088] (Example 3: Pipetter Dispensing Volume Adjustment)

[0089] A fluid handler loads two diagnostic reagents onto an immunoassay analyzer. The first diagnostic reagent comprises the analyte and the second diagnostic reagent comprises an antibody. A mixture of the two diagnostic reagents is produced, with one of the two diagnostic reagents being significantly more abundant than the other diagnostic reagent. The mixture is then sent to a mass spectrometer. The mass spectrometer quantifies the number of analyte / antigen complexes due to molecular weight shift (FIG. 11) and a bias is calculated from the measured signal / expected signal. If the measured value is not within a predefined threshold, a factor (=1 / bias) is applied to the target pipettor motor step.

[0090] Example 4: Testosterone

[0091] The Access Testosterone Assay Kit (commercially available from Beckman Coulter, Inc., Brea, Calif.) can be used for initial testing for testosterone in biological samples. The assay can be run on an immunological assay analyzer of a sample processing system. The Access Testosterone Assay is a competitive binding immunoenzymatic assay that uses mouse monoclonal anti-testosterone antibodies, testosterone alkaline phosphatase conjugates, and paramagnetic particles coated with goat anti-mouse polyclonal antibodies. Testosterone in the sample is released from the carrier protein and competes with the testosterone alkaline phosphatase conjugate for binding sites for a limited amount of specific anti-testosterone monoclonal antibodies. The resulting antigen / antibody complex is then bound to the solid phase by the capture antibody. After incubation in the reaction vessel, the material bound to the solid phase is retained in a magnetic field while unbound material is washed away. The chemiluminescent substrate Lumi-Phos*530 is then added to the vessel and the light generated by the reaction is measured using a luminance meter. Light production is inversely proportional to the concentration of testosterone in the sample. The amount of analyte in the sample is determined from a stored multi-point calibration curve generated from mass spectrometer measurements of a calibrator dilution series prepared from the high concentration calibrator in the Access Testosterone Kit.

[0092] Example 5: Amphetamine

[0093] A clinical laboratory automation system according to an embodiment of the present disclosure can be used to test for drugs of abuse. One exemplary drug of abuse type is amphetamine. Amphetamine is a central nervous system stimulant that produces a feeling of wakefulness, alertness, increased energy, reduced hunger, and an overall state of well-being.

[0094] Amphetamine appears in urine within 3 hours of any type of administration and can be detected by Emit® II and amphetamine assays (commercially available from Beckman Coulter Inc., Brea, CA) for as long as 24-48 hours from the last dose. Emit® II and amphetamine assays are homogeneous enzyme immunoassays. The assays are based on competition between the drug in the sample and the drug labeled with the enzyme glucose-6-phosphate dehydrogenase (G6PDH) for antibody binding sites. Enzyme activity decreases in response to binding to the antibody, so that the drug concentration in the sample can be measured in terms of enzyme activity. The active enzyme converts nicotinamide adenine dinucleotide (NAD) to NADH, resulting in an absorbance change that is measured spectrophotometrically. Endogenous serum G6PDH does not interfere, as the coenzyme NAD functions only with the bacterial (Leuconostoc mesenteroides) enzyme employed in the assay.

[0095] Reagents used in the test may include mouse monoclonal antibodies against dextroamphetamine (61 μg / mL) and d-methamphetamine (10 μg / mL), glucose-6-phosphate (5.5 mM), nicotinamide adenine dinucleotide (3.5 mM), bovine serum albumin, amphetamine labeled with bacterial G6PDH (0.72 U / mL), TRIS buffer, preservatives, and stabilizers. Processed samples are analyzed and compared to assay thresholds generated from mass spectrometer measurements of calibrator dilutions prepared from calibrators in the assay kit according to exemplary embodiments.

[0096] Example 6: Heart Disease and Stroke

[0097] In some embodiments, the clinical laboratory automation system can be used to detect the risk of having heart disease or stroke. Many forms of cardiovascular disease begin with atherosclerosis, a condition in which arteries become hardened and narrowed due to plaque buildup around the arterial walls. Plaque, which consists of cholesterol, fatty substances, cellular waste products, calcium, and fibrin, can partially or completely block the flow of blood through arteries in the heart, brain, pelvis, legs, arms, or kidneys. This blockage can develop into serious diseases such as coronary heart disease, chest pain, carotid artery disease, peripheral artery disease (PAD), and chronic kidney disease. Even worse, if a piece of plaque breaks off or a blood clot (thrombus) forms on the surface of the plaque, a heart attack or stroke can result.

[0098] Several lipoprotein markers are good biomarkers for heart disease and stroke can be measured from fluid samples collected from patients, such as blood, plasma, and serous fluid, using a mass spectrometer. These markers include B-type natriuretic peptide (BNP), proBNP (the inactive prohormone that produces BNP), human C-reactive protein (hs-CRP), and pregnancy-associated plasma protein A (PAPP-A). Many of these natriuretic peptides can aid in determining risk of plaque progression and stroke onset. Other markers include triglycerides to HDLp (high density lipoprotein) ratios, lipophorin / cholesterol ratios, lipid / lipophorin ratios, LDL cholesterol levels, HDLp and apolipoprotein levels, lipophorin and LTP ratios, sphingolipids, omega-3 index, and ST2 levels that can be assayed using the mass spectrometer or analyzer component of the automated system. Quantitative measurements can be determined based on a calibration curve generated from mass spectrometer measurements of calibrator dilutions. The measurements can be compared to reference ranges according to pre-established rules to determine risk of heart disease or stroke.

[0099] If a small fraction of the tumor markers is indicated as positive according to the mass spectrometer data, the control system in the sample processing system commands the sample preparation module in the immunoassay analyzer to prepare and process a second aliquot of the sample. The immunoassay analyzer then detects a fraction of the tumor markers using a multiplex fluorescence-based sandwich immunoassay. The assay can involve adding to the sample aliquot a primary antibody specific to each tumor marker in the fraction and a detection antibody conjugated to a fluorophore and capable of recognizing each of the primary antibodies. The fluorophores have different excitation and emission wavelengths, so the fluorescent signals from the detection antibodies will not interfere with each other. The fluorescent signal from each of the detection antibodies is measured, which represents the amount of each of the corresponding tumor markers in the sample. The results of the tumor markers determined to be positive by the immunoassay analyzer are then reported.

[0100] The above description is illustrative and not restrictive. Many variations of the invention will become apparent to those skilled in the art upon review of this disclosure. The scope of the invention should therefore not be determined with reference to the above description, but instead with reference to the appended claims along with their full scope or equivalents.

[0101] All patents, patent applications, publications, and descriptions mentioned above are incorporated herein by reference in their entirety.

Claims

1. 1. A clinical laboratory automation system, comprising: a fluid handling system including a container handler, at least one fluid container, and a pipettor arrangement, the fluid handling system configured to dispense at least one fluid into the at least one fluid container; An analytical component; a mass spectrometer configured to evaluate at least a property of the at least one fluid, thereby producing a corresponding set of values; Equipped with The analytical component is calibrated, at least in part, using the corresponding set of values.

2. 10. The clinical laboratory automation system of claim 1, wherein the clinical laboratory automation system is further configured to evaluate the pipettor configuration for dispense inaccuracy using at least the corresponding set of values.

3. The clinical laboratory automation system of claim 1 , wherein the analytical component comprises an immunological assay analyzer.

4. 10. The clinical laboratory automation system of claim 1, wherein the analytical component comprises a clinical chemistry analyzer, a protein chemistry analyzer, a hematology analyzer, or a urinalysis analyzer.

5. 10. The clinical laboratory automation system of claim 1, further comprising a sample pipetter station.

6. A clinical laboratory automation system according to any preceding claim, wherein the pipettor arrangement comprises a pump, the pump being driven by an actuator.

7. 10. The clinical laboratory automation system of claim 1, wherein the at least one fluid is selected from the group consisting of a calibrator, a diagnostic reagent, a diluent, or a mixture thereof.

8. 8. The clinical laboratory automation system of claim 7, wherein the calibrator comprises at least one type of analyte or antibody.

9. 6. The clinical laboratory automation system of claim 5, wherein the pipettor arrangement further comprises at least a first pipettor, the first pipettor configured to dispense at least one required volume of a fluid.

10. 10. The clinical laboratory automation system of claim 9, wherein the fluid handling system is configured to dispense at least two fluids, preferably a first fluid and a second fluid.

11. 11. The clinical laboratory automation system of claim 10, wherein the first fluid is a diluent and the second fluid is a calibrator.

12. 12. The clinical laboratory automation system of claim 11, wherein the fluid handling system is configured to produce a dilution series of the calibrator, the dilution series comprising at least one dilution of the calibrator.

13. 13. The clinical laboratory automation system of claim 12, wherein the evaluated characteristic is a concentration of the at least one dilution of the calibrator from the set of dilution series of the calibrator.

14. 14. The clinical laboratory automation system of claim 13, wherein an RLU-dose conversion curve is generated from the corresponding set of values, and the analytical component is calibrated at least in part using the RLU-dose conversion curve.

15. 11. The clinical laboratory automation system of claim 10, wherein the first fluid is a first diagnostic reagent, the second fluid is a second diagnostic reagent, and the property evaluated is quantification of a mixture of the first diagnostic reagent and the second diagnostic reagent.

16. 16. The clinical laboratory automation system of claim 15, wherein quantifying the mixture of diagnostic reagents comprises quantifying the mixture of the first diagnostic reagent and the second diagnostic reagent by molecular weight shift.

17. 17. The clinical laboratory automation system of claim 16, wherein if the dispense inaccuracy is determined, the motor steps of the actuator are adjusted as necessary to dispense each volume.

18. 17. The clinical laboratory automation system of claim 16, wherein if the dispensing inaccuracy is determined, the pipettor configuration is calibrated, at least in part, using the corresponding set of values.

19. The clinical laboratory automation system of claim 1 , wherein at least a portion of said fluid handling system is integrated with said mass spectrometer.

20. 10. The clinical laboratory automation system of claim 1, further comprising a control system configured to control the fluid handling system, the analytical component, and / or the mass spectrometer.

21. 1. A method for adjusting a pipettor dispense volume, the method comprising: Providing a clinical laboratory automation system; The clinical laboratory automation system comprises: (a) a fluid handling system including a container handler, at least one fluid container, and a pipettor arrangement, the pipettor arrangement comprising at least a first pipettor, at least a second pipettor, and a pump, the pump being driven by an actuator, the first pipettor configured to dispense a first required volume of a first fluid into a fluid container, and the second pipettor configured to dispense a second required volume of a second fluid into the same fluid container, the first fluid being a first diagnostic reagent, the second fluid being a second diagnostic reagent, the first diagnostic reagent comprising an analyte, and the second diagnostic reagent comprising an antibody or an antigen; (b) an immunoassay analyzer or a clinical chemistry analyzer; and (c) a mass spectrometer (106) configured to quantify the mixture of the first diagnostic reagent and the second diagnostic reagent, thereby producing a corresponding set of values; Equipped with The method of claim 1, wherein the clinical laboratory automation system is further configured to evaluate the pipettor arrangement for a dispensing inaccuracy using at least the corresponding set of values, and if a dispensing inaccuracy is determined, the actuator is adjusted as necessary to dispense the respective volume.

22. 1. A method for providing variable dilution of a fluid, the method comprising: providing a fluid handling system including a container handler, at least a first fluid container, and a pipettor arrangement, the pipettor arrangement comprising at least a first pipettor and a second pipettor, the fluid handling system configured to produce a set of serial dilutions of a calibrator; Providing a calibrator; Providing a diluent; diluting said calibrator into a diluent; Including, Diluting the calibrator into a diluent comprises: Dispensing a required first volume of said diluent into a first fluid container (103) using said pipettor arrangement; Dispensing a required first volume of said calibrator into said first fluid container (103) using said pipettor arrangement; By, method.